Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
LTX-608 by Talphera for Disseminated Intravascular Coagulation (DIC): Likelihood of Approval
LTX-608 is under clinical development by Talphera and currently in Phase III for Disseminated Intravascular Coagulation (DIC). According to GlobalData,...
Data Insights
LTX-608 by Talphera for Coronavirus Disease 2019 (COVID-19): Likelihood of Approval
LTX-608 is under clinical development by Talphera and currently in Phase III for Coronavirus Disease 2019 (COVID-19). According to GlobalData,...